Cipla agrees to buy South African pharma maker for INR 225 cr
Cipla said it has agreed to buy South African pharmaceuticals maker Mirren for 450 mln rand, or about INR 225 cr.
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 145
Browsing Category
Latest Updates
Drug regulator orders recall of Novartis’s painkiller diclofenac
Drug controller general of India (DCGI ) cancels licence for diclofenac sold by Novartis after concerns raised by a health…
DRL to appeal against US court decision
The US court barred DRL from sales and commercialisation of Buprenorphine and Naloxone Sublingual Film
Delhi hosts third edition of Healthcare Senate
Leaders and game changers in India’s private healthcare sector came together at the event organised by Express Healthcare and The…
Lupin receives FDA approval for Nitrofurantoin capsules
Lupin receives FDA approval for Nitrofurantoin capsules
Zydus Hospira receives EIR for Ahmedabad facility
US FDA audited the manufacturing plant from April 5 - 12, 2018
Alembic receives US FDA tentative approval for Ticagrelor Tablets, 90 mg
Ticagrelor tablets are indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with…
Cipla Medpro strengthens footprint in South Africa
The company plans to grow by acquiring 100 per cent stake in Mirren
Zydus to market Zolmitriptan tablets
Tablets will be manufactured at group’s manufacturing facility in Ahmedabad
Novartis invites applications for BioCamp 2018
BioCamp offers 50 top tier students four-day hands-on experience with the multifaceted world of pharma and direct interaction with…